非酒精性脂肪性肝病的药物治疗进展

被引：21

作者：

丁雯瑾

范建高

机构：

[1] 上海交通大学医学院附属新华医院消化内科

来源：

胃肠病学 | 2009年 / 14卷 / 07期

关键词：

非酒精性脂肪肝; 药物疗法; 减肥药; 降脂药; 利胆保肝药; 中草药;

D O I：

暂无

中图分类号：

R575 [肝及胆疾病];

学科分类号：

100201 [内科学];

摘要：

非酒精性脂肪性肝病(NAFLD)主要表现为肝实质细胞脂肪变性和脂肪沉积,可在脂肪肝、肝炎基础上进展为肝纤维化和肝硬化,甚至出现肝衰竭或其他并发症。因此有必要在调整生活方式的同时加以药物干预。治疗NAFLD的药物大致分为三类:控制危险因素的药物、利胆保肝药和中药。本文主要就NAFLD的药物治疗作一概述。

引用

页码：442 / 445

页数：4

共 13 条

[1]

Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: A pilot study [J].

Enjoji, Munechika ;

Kotoh, Kazuhiro ;

Kato, Masaki ;

Higuchi, Nobito ;

Kohjima, Motoyuki ;

Nakashima, Manabu ;

Nakamuta, Makoto .

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 22 (04) :521-527

[2]

Weight loss; dietary advice and statin therapy in non‐alcoholic fatty liver disease: a retrospective study.[J].P.Riley;D.Sudarshi;M.Johal;A.Benedict;J.Panteli;M.Crook;J.O’Donohue.International Journal of Clinical Practice.2008, 3

[3]

Vitamin E in Chronic Liver Diseases and Liver Fibrosis.[J].Antonio Di Sario;Cinzia Candelaresi;Alessia Omenetti;Antonio Benedetti.Vitamins and Hormones.2007,

[4]

Use of insulin sensitizers in NASH [J].

Khashab, Mouen ;

Chalasani, Naga .

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2007, 36 (04) :1067-+

[5]

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis [J].

Kiyici, M ;

Gulten, M ;

Gurel, S ;

Nak, SG ;

Dolar, E ;

Savci, G ;

Adim, SB ;

Yerci, O ;

Memik, F .

CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (12) :713-718

[6]

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone [J].

Neuschwander-Tetri, BA ;

Brunt, EM ;

Wehmeier, KR ;

Oliver, D ;

Bacon, BR .

HEPATOLOGY, 2003, 38 (04) :1008-1017

[7]

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis [J].

Basaranoglu, M ;

Acbay, O ;

Sonsuz, A .

JOURNAL OF HEPATOLOGY, 1999, 31 (02) :384-384

[8]

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study [J].

Laurin, J ;

Lindor, KD ;

Crippin, JS ;

Gossard, A ;

Gores, GJ ;

Ludwig, J ;

Rakela, J ;

McGill, DB .

HEPATOLOGY, 1996, 23 (06) :1464-1467

[9]

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents..Nadeau KJ;Ehlers LB;Zeitler PS;Love-Osborne K;.Pediatr Diabetes.2009, 10

[10]

脂肪肝中医治疗研究进展 [J].

高永坤 .

中国现代医生, 2008, (07) :77+84

← 1 2 →